Skip to content

Drug interactions

Mexiletine + Ritlecitinib

Severity: Moderate

Mexiletine and Ritlecitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritlecitinib inhibits CYP1A2 and may increase exposure to CYP1A2 substrates, and mexiletine is partly cleared by this pathway. Higher mexiletine levels could increase neurological and cardiac adverse effects.

What this interaction means in plain words

Mexiletine and Ritlecitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mexiletine belongs to Cardiovascular; Ritlecitinib belongs to Oncology.

Evidence level: Low

Why it happens

Ritlecitinib inhibits CYP1A2, reducing mexiletine clearance.

What to do

Monitor for mexiletine toxicity (tremor, dizziness, nausea) and consider reducing the dose, using plasma levels if available.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mexiletine and Ritlecitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mexiletine with Ritlecitinib?

MediHelp rates the interaction as moderate. Mexiletine and Ritlecitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ritlecitinib inhibits CYP1A2 and may increase exposure to CYP1A2 substrates, and mexiletine is partly cleared by this pathway. Higher mexiletine levels could increase neurological and cardiac adverse effects.

How serious is the interaction between Mexiletine and Ritlecitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for mexiletine toxicity (tremor, dizziness, nausea) and consider reducing the dose, using plasma levels if available.

What other medicines interact with Mexiletine?

MediHelp also lists interactions of Mexiletine with, for example, Fezolinetant, Pimozide, Alosetron. The full list is on the Mexiletine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in